Should N-methyl-D-aspartate or non-N-methyl-D-aspartate glutamate receptor antagonist be used in amyotrophic lateral sclerosis?
Blin
O
O
Department of Clinical Pharmacology, Timone University Hospital, Marseille, France.
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D004195:Disease Models, Animal; D018691:Excitatory Amino Acid Antagonists; D006801:Humans; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate